Related Experiment Video
Updated: Feb 3, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Image-Guided Cancer Nanomedicine
1Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Image-guided nanomedicine offers a promising solution to overcome challenges in nanomedicine, such as poor targeting and tumor heterogeneity. This approach aims to improve therapeutic efficacy by enabling precise nanoparticle delivery for enhanced cancer treatment.
Area of Science:
- Nanomedicine
- Oncology
- Biomedical Imaging
Background:
- Multifunctional nanoparticles are developed for enhanced imaging and therapy in nanomedicine.
- Tumor barriers and heterogeneity limit in vivo therapeutic efficacy of nanotherapeutics.
- Poor targeting efficiency and nanoparticle toxicity are significant challenges in nanomedicine.
Purpose of the Study:
- To review current challenges in nanomedicine.
- To discuss the potential of image-guided nanomedicine.
- To explore future prospects for image-guided nanomedicine.
Main Methods:
- Literature review of nanomedicine challenges.
- Analysis of image-guided nanomedicine strategies.
- Discussion of interventional oncology techniques for nanoparticle delivery.
Main Results:
- Nanoparticle-based therapies face significant in vivo efficacy limitations.
- Image-guided nanomedicine presents a novel approach to enhance targeted delivery.
- Non-invasive imaging and interventional oncology are key to localized nanoparticle delivery.
Conclusions:
- Image-guided nanomedicine is a promising strategy to address nanomedicine challenges.
- Precise nanoparticle delivery can overcome tumor-intrinsic barriers and heterogeneity.
- Future research should focus on integrating imaging and therapeutic interventions for improved outcomes.
More Related Videos
08:36Ultrasound Imaging-guided Intracardiac Injection to Develop a Mouse Model of Breast Cancer Brain Metastases Followed by Longitudinal MRI
Published on: March 6, 2014
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...